Cosentyx 150MG/ML 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUGS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,363
Award facts
- Contract value 100% obligated
- $12,363.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 26, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,363.03 to AmerisourceBergen Drug Corp for the supply of COSENTYX 150MG/ML (secukinumab), a biologic immunosuppressant medication used to treat inflammatory conditions. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's parent company Cencora, Inc., is scheduled for completion by January 27, 2026, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. The award utilized competitive procedures with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements.
This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. The IDC serves military healthcare systems worldwide and enables the delivery of specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical supplies across multiple therapeutic domains. Through this contract structure, AmerisourceBergen fulfills critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities, demonstrating its role as a major pharmaceutical distributor within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FAUGS?
SPE2DR26FAUGS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FAUGS worth?
The government has obligated $12,363 on SPE2DR26FAUGS.
Is contract SPE2DR26FAUGS an order under another contract?
Yes. SPE2DR26FAUGS is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUGS competed?
The extent of competition for SPE2DR26FAUGS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award